Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies

American Journal of Hematology
Louis M AledortITP Study Group

Abstract

Immune thrombocytopenia purpura (ITP) is characterized by destruction of circulating platelets and the presence of antiplatelet antibodies. Many of the current immunomodulatory therapies act by reducing platelet destruction and usually do not have a lasting effect. This prospective, exploratory study characterized patients with ITP by identifying their demographic and comorbid clinical factors, use of treatments, serologic markers of autoimmunity, and possible relationships between platelet counts, concentrations of endogenous thrombopoietin (eTPO), and the presence of circulating anti-TPO antibodies. Data including medical history and laboratory evaluations were collected at a single patient visit on 205 patients (19 children, 186 adults). Reported histories revealed a 5% rate of thrombotic/ischemic events. Autoimmune markers including direct antiglobulin test and antinuclear antibodies were found more frequently than in the normal population; antiplatelet antibody testing was not done. eTPO concentrations were comparable to concentrations found in healthy volunteers. Our study confirmed that no significant inverse correlation occurred between circulating concentrations of eTPO and platelet counts in patients with ITP (Spearma...Continue Reading

References

Feb 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T SaphnerR Gray
May 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·J S GreenbergerR J Eckner
Nov 8, 1994·Proceedings of the National Academy of Sciences of the United States of America·D J KuterR D Rosenberg
Jun 30, 1994·The New England Journal of Medicine·J A Mills
Jul 1, 1995·Journal of Biochemistry·T KatoE Maeda
Jun 1, 1996·British Journal of Haematology·S KosugiY Matsuzawa
Dec 1, 1996·British Journal of Haematology·J C MarshE C Gordon-Smith
Jul 1, 1997·Journal of Pediatric Hematology/oncology·S A Zimmerman, R E Ware
Mar 3, 1998·Journal of Pediatric Hematology/oncology·M U KueferC W Jackson
Jul 17, 1998·Current Opinion in Hematology·J L Nichol
Feb 26, 2000·Clinical Cornerstone·A Kavanaugh
Oct 31, 2000·Current Opinion in Hematology·N Manny, O Zelig
Jan 5, 2002·American Journal of Hematology·L RiceM Bacile
Mar 29, 2002·The New England Journal of Medicine·Douglas B Cines, Victor S Blanchette

❮ Previous
Next ❯

Citations

Feb 16, 2010·Annals of Hematology·Vibha JawaNarendra Chirmule
Sep 27, 2013·International Journal of Hematology·Anne ContisJean-François Viallard
Apr 25, 2008·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·I Leonard BernsteinUNKNOWN American College of Allergy, Asthma and Immunology
Aug 26, 2011·The New England Journal of Medicine·Paul Imbach, Mark Crowther
Oct 20, 2006·The New England Journal of Medicine·James B BusselJanet L Nichol
Nov 30, 2007·The New England Journal of Medicine·James B BusselJulian M Jenkins
Jun 26, 2009·Current Opinion in Hematology·Adrian Newland
Jan 17, 2008·Current Opinion in Pediatrics·Ram Kalpatthi, James B Bussel
Sep 29, 2012·AIDS·Eva ZetterbergUNKNOWN INSIGHT SMART Study Group
Jan 18, 2011·Hematology·Adam Cuker, Douglas B Cines
Feb 8, 2008·Blood·Tobias GoergeDenisa D Wagner
Apr 28, 2009·Blood·Douglas B CinesEline T Luning Prak
Mar 16, 2005·International Journal of Hematology·Kiarash Kojouri, James N George
May 12, 2012·Mediators of Inflammation·Enrico LupiaGiuseppe Montrucchio
Mar 19, 2014·La Presse médicale·Douglas B CinesJohn W Semple
Dec 3, 2014·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·M CotillonN Buchbinder
Apr 5, 2014·Medicina clínica·Carlos Grande GarcíaUNKNOWN Grupo de estudio de Trombocitopenia Inmune Primaria de la Sociedad Española de Hematología y Hemoterapia y Sociedad Española
Sep 19, 2014·International Journal of Hematology·Caizheng Li, Li Zheng
May 21, 2013·Expert Opinion on Biological Therapy·Simon HallamAdrian C Newland
Oct 10, 2014·Scandinavian Journal of Clinical and Laboratory Investigation·Raymond S M WongAndres Brainsky
May 30, 2013·Hematology/oncology Clinics of North America·Gaurav Kistangari, Keith R McCrae
Nov 9, 2015·American Journal of Hematology·Francesco Rodeghiero
Jul 14, 2010·Seminars in Hematology·Adam Cuker
Apr 23, 2010·La Revue de médecine interne·S AudiaB Bonnotte
Nov 26, 2009·Hematology/oncology Clinics of North America·Carolyn M Bennett, Michael Tarantino
Aug 2, 2007·Hematology/oncology Clinics of North America·Bethan Psaila, James B Bussel
Feb 10, 2007·Autoimmunity Reviews·Alejandro Ruiz-Argüelles, Luis Llorente
Jun 25, 2008·British Journal of Haematology·Bethan Psaila, James B Bussel
Aug 2, 2006·Journal of Thrombosis and Haemostasis : JTH·J N George
Apr 29, 2006·British Journal of Haematology·Nichola Cooper, James Bussel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.